163 related articles for article (PubMed ID: 17350065)
1. Non-invasive fluorescent imaging of gliosis in transgenic mice for profiling developmental neurotoxicity.
Ho G; Zhang C; Zhuo L
Toxicol Appl Pharmacol; 2007 May; 221(1):76-85. PubMed ID: 17350065
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of retinal gliosis in transgenic mice induced by kainic acid neurotoxicity.
Ho G; Kumar S; Min XS; Kng YL; Loh MY; Gao S; Zhuo L
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2459-64. PubMed ID: 19151398
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model.
Kumar S; Zhuo L
Exp Eye Res; 2010 Oct; 91(4):530-6. PubMed ID: 20655908
[TBL] [Abstract][Full Text] [Related]
4. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
O'Callaghan JP; Martin PM; Mass MJ
Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
[TBL] [Abstract][Full Text] [Related]
5. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
[TBL] [Abstract][Full Text] [Related]
6. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.
Nolte C; Matyash M; Pivneva T; Schipke CG; Ohlemeyer C; Hanisch UK; Kirchhoff F; Kettenmann H
Glia; 2001 Jan; 33(1):72-86. PubMed ID: 11169793
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive imaging of GFAP expression after neuronal damage in mice.
Zhu L; Ramboz S; Hewitt D; Boring L; Grass DS; Purchio AF
Neurosci Lett; 2004 Sep; 367(2):210-2. PubMed ID: 15331155
[TBL] [Abstract][Full Text] [Related]
8. Protracted exposure to supraphysiological levels of corticosterone does not cause neuronal loss or damage and protects against kainic acid-induced neurotoxicity in the hippocampus of C57BL/6J mice.
Benkovic SA; O'Callaghan JP; Miller DB
Neurotoxicology; 2009 Nov; 30(6):965-76. PubMed ID: 19616023
[TBL] [Abstract][Full Text] [Related]
9. Identification of a human glial fibrillary acidic protein cDNA: a tool for the molecular analysis of reactive gliosis in the mammalian central nervous system.
Rataboul P; Faucon Biguet N; Vernier P; De Vitry F; Boularand S; Privat A; Mallet J
J Neurosci Res; 1988; 20(2):165-75. PubMed ID: 3139890
[TBL] [Abstract][Full Text] [Related]
10. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice.
Otani N; Nawashiro H; Fukui S; Ooigawa H; Ohsumi A; Toyooka T; Shima K; Gomi H; Brenner M
J Clin Neurosci; 2006 Nov; 13(9):934-8. PubMed ID: 17085299
[TBL] [Abstract][Full Text] [Related]
11. Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice.
Benkovic SA; O'Callaghan JP; Miller DB
Brain Res; 2006 Jan; 1070(1):215-31. PubMed ID: 16403473
[TBL] [Abstract][Full Text] [Related]
12. Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice.
Chen Z; Duan RS; Quezada HC; Mix E; Nennesmo I; Adem A; Winblad B; Zhu J
J Neurobiol; 2005 Feb; 62(2):207-18. PubMed ID: 15459893
[TBL] [Abstract][Full Text] [Related]
13. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.
Samland H; Huitron-Resendiz S; Masliah E; Criado J; Henriksen SJ; Campbell IL
J Neurosci Res; 2003 Jul; 73(2):176-87. PubMed ID: 12836160
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of complement protein C3 in dying pyramidal neurons in rat hippocampus after systemic administration of kainic acid.
Morita H; Suzuki K; Mori N; Yasuhara O
Neurosci Lett; 2006 Nov; 409(1):35-40. PubMed ID: 17014960
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging reveals a correlation between 2'-CH3-MPTP-induced neonatal neurotoxicity and dopaminergic neurodegeneration in adult transgenic mice.
Ho G; Kumar S; Zhang C; Kng YL; Zhuo L
Int J Dev Neurosci; 2008 Nov; 26(7):673-81. PubMed ID: 18703131
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
17. Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.
Cho IH; Kim SW; Kim JB; Kim TK; Lee KW; Han PL; Lee JK
J Neurosci Res; 2006 Nov; 84(7):1505-11. PubMed ID: 16958132
[TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress.
Hanstein R; Lu A; Wurst W; Holsboer F; Deussing JM; Clement AB; Behl C
Neuroscience; 2008 Oct; 156(3):712-21. PubMed ID: 18708129
[TBL] [Abstract][Full Text] [Related]
19. Detection and semi-quantitative determination of low abundance GFAP mRNA in mouse brain by capillary electrophoresis coupled with laser-induced fluorescence.
Khan HA
Brain Res Brain Res Protoc; 2004 Nov; 14(1):13-7. PubMed ID: 15519947
[TBL] [Abstract][Full Text] [Related]
20. Chronic gliosis induced by loss of S-100B: knockout mice have enhanced GFAP-immunoreactivity but blunted response to a serotonin challenge.
Chang MS; Ariah LM; Marks A; Azmitia EC
Brain Res; 2005 Jan; 1031(1):1-9. PubMed ID: 15621007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
